PAD Formulary : Surrey Heartlands
PAD - Prescribing Advisory Database
PLEASE NOTE : This is a development system.

For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.

You are here : Home > PAD Profile : Eletriptan - Migraine (acute)

PAD Profile : Eletriptan - Migraine (acute)

Keywords :
Triptans, acute migraine, migraine treatment
Brand Names Include :
Relpax

Traffic Light Status

Status 1 of 1.

Status :
Green (see narrative)
Important
Formulations :
  • Tablets
Important Information :
Not 1st line. Generic sumatriptan, naratriptan, rizatripan, zolmitriptan are preferred.
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Links :
BNF NICE SPC
Comments :
No comments returned.
Documents :

Guidelines

No guidelines returned.

Other Drugs

Other Indications

No indications returned.

Additional Documents

No additional documents returned.

Committee Recommendations

Date
Committee Name
Narrative
02 March 2016
Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)
UPDATED: The PCN recommends that Frovatriptan, almotriptan and eletriptan should be considered as alternatives after trials of the generically available triptans, where clinically appropriate

Associated BNF Codes

04. Central Nervous System
04.07.04. Antimigraine drugs
This site uses its own and third party cookies to function properly and to improve performance, to maintain the session and to personalise user experience, as well as to obtain anonymous statistics about the use of the website. Visit our Privacy and Cookie Policy for more information on our data collection practices. By clicking 'Accept' you agree to our use of cookies for the purposes listed.
 Learn More